Cancer Institute– A national cancer institute
designated cancer center

Daniel Bloch

Back to Profile

Publication Details

  • The relative toxicity of disease-modifying antirheumatic drugs.

    Fries JF, Williams CA, Ramey D, Bloch DA. Arthritis Rheum. 1993; 36 (3): 297-306

    To compare the toxicities of commonly employed disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA).

    PubMedID: 8452574

Stanford Medicine Resources:

Footer Links: